Spruce Biosciences, Inc. (NASDAQ: SPRB) reported Q2 EPS of ($0.32), $0.07 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $750 thousand.

For earnings history and earnings-related data on Spruce Biosciences, Inc. (SPRB) click here.